Raleigh/Durham, NC, September 28, 2009 – Smith & Nephew (NYSE:SNN; LSE: SN) Biologics & Spine has launched an innovative new system for performing transforaminal epidural injections.
The TRUCATH™ Spinal Injection System is designed to help reduce the risks1 associated with epidural pain management procedures.
The unique design enables the physician to position the needle outside the boney structure of the spine, accurately delivering the catheter to the correct transforaminal entry point and reducing the potential for venous and arterial trespass.
Some 80 % of the US population1 will suffer from neck or back pain at some point in their lives and an estimated seven million transforaminal epidural injections are expected to be administered this year.
The new injection system was previewed to spine pain management specialists at the recent Association of Interventional Pain Physicians (ASIPP) in Washington D.C. and the International Spine Intervention Society Annual Scientific Meeting in Toronto, Canada.